Is Stemline Therapeutics Inc (NASDAQ:STML) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top ...

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do ...

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required ...

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and ...

Stemline Therapeutics, Inc. (NASDAQ:STML) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the ...

Investors are always looking for stocks that are poised to beat at earnings season and Stemline Therapeutics, Inc. ( STML) may be one such company. The firm has earnings coming up pretty soon, and ...

Investors are always looking for stocks that are poised to beat at earnings season and Stemline Therapeutics, Inc. STML may be one such company. The firm has earnings coming up pretty soon, and events ...

A statement released by Stemline Therapeutics (STML) late yesterday amounted to the first official confirmation of a second patient death on a pivotal trial of the group’s lead asset, SL-401. Rumors ...

Stemline Therapeutics, Inc. has just filed its paperwork with the Securities and Exchange Commission that will allow it to conduct an initial public offering. The company will list is shares under the ...